Tag: NeuroOne

NeuroOne submits special 510(k) to US FDA for Evo sEEG electrode

NeuroOne Medical Technologies has announced the submission of a special 510(k) to the US Food and Drug Administration (FDA) for its stereoelectroencephalography (sEEG) electrode...

NeuroOne announces first clinical case using Evo sEEG electrode technology

NeuroOne Medical Technologies today announced that the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode was recently performed by Robert Gross at Emory University in...

NeuroOne releases successful completion of long-term stimulation tests with novel, thin-film...

NeuroOne Medical Technologies has announced that it successfully completed initial, bench-top, long-term stimulation testing on a novel design of its thin-film electrode technology. The...

NeuroOne releases successful long-term recording data with novel electrode technology

NeuroOne Medical Technologies has announced that it successfully completed initial preclinical, long-term testing of recording capabilities on its thin-film platform electrode technology. In test...

NeuroOne successfully completes feasibility study of Evo ablation electrode

NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its combination recording and ablation technology at T3 Labs and...
neuroone evo technology

NeuroOne Medical Technologies gains FDA 510(k) clearance for Evo SEEG electrode

NeuroOne Medical Technologies—a company focused on improving surgical care options and outcomes for patients with neurological disorders—has announced that it has received US Food...